tetraethylammonium has been researched along with Lymph Node Metastasis in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skryma, R | 1 |
| Van Coppenolle, F | 1 |
| Dufy-Barbe, L | 1 |
| Dufy, B | 1 |
| Prevarskaya, N | 1 |
1 other study available for tetraethylammonium and Lymph Node Metastasis
| Article | Year |
|---|---|
Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line.
Topics: Adenocarcinoma; Calcium; Charybdotoxin; Elapid Venoms; Humans; Ion Channel Gating; Ion Transport; Ly | 1999 |